Pancreatic Cancer Research

ResearcherAIM ImmunoTech Inc.Active in the last 2 years

David R Strayer

Provisional: name at one institution (moderate confidence)As of 15 November 2026

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
0
Pancreatic cancer trials
1
Pancreatic cancer grants
0
Collaborators
0
Papers, trials and grants by year

2027: 1 trial

Trials 1

  1. Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC Study director NCT05494697↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.